# Welcome to my webpage

## Aboute Me
ğŸ‘‹ Hi, Iâ€™m Vivek Das and you can find me in LinkedIn https://www.linkedin.com/in/vivek-das-phd-m-sc-b1110b25/

ğŸ‘€ I work on finding therapeutic target or biomarkers (prognostic/predictive) for multiple cardiometabolic (e.g. Chronic Kidney, Atherosclerosis, Diabetes, Liver, Neurodegenrative, etc.) diseases combining data-driven and knowledge-driven avenues by leveraging the integration of bulk and single cell multi-omics data alongside clinical data from human observational cohorts and clinical trials

ğŸŒ± I currently collaborate, lead studies or projects and team of exceptional clinical data scientists and bioinformaticians involving single-cell transcriptomics, spatial transcriptomics, proteomics, metabolomics, multi-omics data integration, clinical data integration to achieve the above

ğŸ’» I also worked on omics projects involving preclinical data with interventional designs e.g. knockout or drug treated at single cell or bulk multi-omics level

ğŸ’ï¸ I also collaborate on developing applied machine learning models using publicly available data with curious students or researchers and contribute to open science and open source modeling. I am fascinated by the potential of high-dimnesional and high-throughput biomedical data.

## Publications

ğŸ“š To read more about our works kindly check out Google Scholar page at: https://scholar.google.it/citations?user=l_Aj58cAAAAJ&hl=en

## Education
- PhD in Molecular Medicine (Curriculum Computational Systems Biology) from European School of Molecular Medicine, SEMM, Milan, Italy (2012-2017)
- Masters in Science in Bioinformatics from Birla Institute of Technology, Mesra, India (2008-2010)
- Bachelor in Biotechnology (Chemistry, Mathematics and Zoology) from PESIAS, Bangalore, India (2005-2008)

## Experience
- **Lead Data Scientist in Novo Nordisk A/S** - 2023 - Present - Clinical Trial Omics & Precision Medicine in Development (Clinical).
  
  Lead, design & implement integrative multi-omics strategies, in-silico analytical frameworks & interpretability in Late-Stage Clinical Trial (CardioRenal and neuronal) settings.
  
- **Senior Research Scientist in Novo Nordisk A/S** - 2021-2023 - Early Drug Discovery.

  In-silico Target and Biomarker discovery using high dimensional bulk/single-cell multi-Omics data, analysis, visualization and integration with clinical phenotypic measurements using advanced statistics and ML

## How to reach out

ğŸ“« vivekdas.0687@gmail.com

## Topic of interest
- Applied Statistics and Applied Machine Learning
- Multi omics and clinical data integration
- Drug Target Identification
- Biomarker Identification
- Drug development
- Big Data in Omics and Healthcare
- Drug development
- Applied LLM in Biology and drug development
- Clinical Trial Design
- Single-cell and multiomics predictive modeling
- Cardiometabolic diseases (Diabetes, Chronic Kidney Disease, Cardiovascular Disease, Liver Disease, Solid Cancers)
- Digital Strategy
- Software products
- Team building
- Leadership
- Mentorshio
- Open source project

